DOCSLIB.ORG

United States Patent (10) Patent No.: US 9,615,530 B2 May (45) Date of Patent: Apr

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
United States Patent (10) Patent No.: US 9,615,530 B2 May (45) Date of Patent: Apr US00961553OB2 (12) United States Patent (10) Patent No.: US 9,615,530 B2 May (45) Date of Patent: Apr. 11, 2017 (54) COTTON VARIETY 14R938B2XF 7,855,326 B2 12/2010 Feng et al. 7,858,764 B1 12/2010 Huberet al. (71) Applicant: MONSANTO TECHNOLOGY LLC, 7,939,721 B2 5/2011 Arnevik et al. St. Louis, MO (US) 8,071,735 B2 12/2011 Cerny et al. s 8,119,380 B2 2/2012 Weeks et al. 8.420,888 B2 4/2013 Feng et al. (72) Inventor: O. Lloyd May, Tifton, GA (US) 8,435,743 B2 5/2013 Cerny et al. 8,629,323 B2 1/2014 Weeks et al. (73) Assignee: Monsanto Technology LLC, St. Louis, 8,735,661 B2 5 2014 Brinker et al. MO (US) 9,024,115 B2 5, 2015 Brinker et al. 9,133,473 B2 9/2015 Huber et al. 9,179,620 B2 11/2015 Ma (*) Notice: Subject to any disclaimer, the term of this 2012/03 11730 A1* 12/2012 NE . A23D 9.00 patent is extended or adjusted under 35 800,260 U.S.C. 154(b) by 0 days. FOREIGN PATENT DOCUMENTS (21) Appl. No.: 14/968,531 WO WO 2004/072235 8, 2004 (22) Filed: Dec. 14, 2015 OTHER PUBLICATIONS (65) Prior Publication Data U.S. Appl. No. 14/968,639, filed Dec. 14, 2015, McGowen. US 2016/0174499 A1 Jun. 23, 2016 U.S. Appl. No. 14/968,547, filed Dec. 14, 2015, May. U.S. Appl. No. 14/996,093, filed Jan. 14, 2016, McGowen. Related U.S. ApplicationO O Data ReleasedBowman Betweenet al., “Pedigrees 19702005, of UplandMississippi and AgriculturalPima Cotton & Cultivars Forestry (60) Provisional application No. 62/095,531, filed on Dec. Experiment Station, Bulletin. 1155. Dec. 2006, 22, 2014 Eshed et al., “Less-than-addictive epistatic interactions of quanti s tative trait loci in tomato,' Genetics, 143: 1807-1817, 1996. Fehr (ed), "Backcross Method.” In: Principles of Cultivar Devel (51) Int. Cl. opment, vol. 1: Theory and Technique, pp. 360-376, 1987. AOIH IM00 (2006.01) Steet.” Theor:i. Appl.E.g. Genet. seqiya,ingerprinting :323-32O, in Sugar AOIH 5/00 (2006.01) Poehlman (ed), “Breeding Corn (Maize).” In: Breeding Field Crops, AOIH 5/10 (2006.01) 3rd Ed., AVI Publishing Company, Westport, Connecticut, pp. CI2N 5/82 (2006.01) 469-481, 1987. (52) U.S. Cl. Poehlman (eds), "Backcross Breeding.” In: Breeding Field Crops, 4th Ed., pp. 172-175, 1995. CPC - - - - - - - - - - - - - - -r r A0IH 5/10 (2013.01) Rieger et al., In: Glossary of Genetics and Cytogenetics, Classical (58) Field of Classification Search and Molecular, Springer-Verlag, Berlin, p. 116, 1976. None Sprague et al. (Eds.), “8-1.1.2 Backcrossing.” In: Corn and See application file for complete search history. Improvement, 3' Ed., Madison, WI, pp. 472-473, 1998. Marchosky et al., “Bollgard(R) and Bollgard IIR Efficacy in Near (56) References Cited Isogenic Lines of DP50. Upland Cotton in Arizona.” Arizona Cotton Report, The University of Arizona College of Agriculture U.S. PATENT DOCUMENTS and Life Sciences, 2001. Phipps et al., “Performance of Roundup FlexC) cotton varieties in 4.940,835. A 7, 1990 Shah the North Mississippipp River Delta,, pp.pp 874-880, 2006 Beltwide 5.338,544 A 8, 1994 Donovan Cotton Conferences, San Antonio, Texas, Jan. 3-6, 2006. 5.45 i. 514 A 9, 1995 Boudet et al. Virginia Cotton Production Guide 2011, College of Agriculture and 5,523.520 A 6/1996 Hunsperger et al. Life Sciences, Virginia Tech, 2011. 5,633,435 A 5/1997 Barry Variety specific information as indicated in transmittal letter of Mar. 5,717,084 A 2f1998 Herrera-Estrella et al. 3, 2016. Information Disclosure Statement of U.S. Appl. No. 5,728,925 A 3, 1998 Herrera-Estrella et al. 14/968,531. 5,850,019 A 12/1998 Maiti et al. 5,981,834 A 11/1999 John et al. * cited by examiner 6,051,753. A 4/2000 Comai et al. g f 3.3. R et al. Primary Examiner — Mykola V. Kovalenko 648954 B 12/2002 Ea. (74) Attorney, Agent, or Firm — Dentons US LLP 6,660,911 B2 12/2003 Fincher et al. 6,740,488 B2 5/2004 Rangwala et al. (57) ABSTRACT 6943.2826.893.826 BiB1 9,5, 2005 HillvardNE et al. The invention relates to the novel cotton variety designated 6949,696 B2 9, 2005 Fincher et al. 14R938B2XF. Provided by the invention are the seeds, 7,022,896 B1 4/2006 Weeks et al. plants, plant parts and derivatives of the cotton variety 7,064.249 B2 6/2006 Corbinet al. 14R938B2XF. Also provided by the invention are methods 7,105,729 B2 9/2006 Mitchell et al. of using cotton variety 14R938B2XF and products derived 7,112,665 B1 9/2006 Leemans et al. therefrom. Still further provided by the invention are meth 7,112,725 B2 9, 2006 Fincher et al. ds f duci 1 b h 7,141,722 B2 11/2006 Fincher et al. O s or produc1ng cotton p ants by crossing the cotton 7,223,907 B2 5, 2007 Huber et al. variety 14R938B2XF with itself or another cotton variety 7,381,861 B2 6/2008 Cerny et al. and plants and seeds produced by Such methods. 7,770,830 B1 8/2010 Langenecker et al. 7,812,224 B2 10/2010 Weeks et al. 22 Claims, No Drawings US 9,615,530 B2 1. 2 COTTON VARIETY 14R938B2XF as one parent, the second generation (F) hybrid cotton plant grown from the seed of the F hybrid plant, and the seeds of This application claims the benefit of U.S. provisional the F hybrid plant. application No. 62/095,531, filed Dec. 22, 2014, which is In a further aspect of the invention, a composition is herein incorporated by reference in its entirety. 5 provided comprising a seed of cotton variety 14R938B2XF comprised in plant seed growth media. In certain embodi BACKGROUND OF THE INVENTION ments, the plant seed growth media is a soil or synthetic cultivation medium. In specific embodiments, the growth 1. Field of the Invention medium may be comprised in a container or may, for The present invention relates generally to the field of 10 example, be soil in a field. Plant seed growth media are well known to those of skill in the art and include, but are in no cotton breeding. In particular, the invention relates to the way limited to, Soil or synthetic cultivation medium. Advan novel cotton variety 14R938B2XF. tageously, plant seed growth media can provide adequate 2. Description of Related Art physical Support for seeds and can retain moisture and/or The goal of a commercial cotton breeding program is to 15 nutritional components. Examples of characteristics for soils develop new, unique and Superior cotton varieties. In cotton, that may be desirable in certain embodiments can be found, important traits include higher fiber (lint) yield, earlier for instance, in U.S. Pat. Nos. 3,932,166 and 4,707,176. maturity, improved fiber quality, resistance to diseases and Synthetic plant cultivation media are also well known in the insects, tolerance to drought and heat, and improved agro art and may, in certain embodiments, comprise polymers or nomic traits. The breeder initially selects and crosses two or hydrogels. Examples of such compositions are described, for more parental lines, followed by generation advancement example, in U.S. Pat. No. 4.241,537. Still yet another aspect of the invention is a method of and selection, thus producing many new genetic combina producing cotton seeds comprising crossing a plant of the tions. The breeder can theoretically generate billions of cotton variety 14R938B2XF to any second cotton plant, different genetic combinations via this procedure. including itself or another plant of the variety 14R938B2XF. 25 In particular embodiments of the invention, the method of SUMMARY OF THE INVENTION crossing comprises the steps of a) planting seeds of the cotton variety 14R938B2XF; b) cultivating cotton plants One aspect of the present invention relates to seed of the resulting from said seeds until said plants bear flowers; c) cotton variety 14R938B2XF. The invention also relates to allowing fertilization of the flowers of said plants; and, d) plants produced by growing the seed of the cotton variety 30 harvesting seeds produced from said plants. 14R938B2XF, as well as the derivatives of such plants. As Still yet another aspect of the invention is a method of used herein, the term “plant' includes plant cells, plant producing hybrid cotton seeds comprising crossing the cot ton variety 14R938B2XF to a second, distinct cotton plant protoplasts, plant cells of a tissue culture from which cotton which is nonisogenic to the cotton variety 14R938B2XF. In plants can be regenerated, plant calli, plant clumps, and plant particular embodiments of the invention, the crossing com cells that are intact in plants or parts of plants. Such as pollen, 35 prises the steps of a) planting seeds of cotton variety flowers, seeds, bolls, leaves, stems, and the like. 14R938B2XF and a second, distinct cotton plant, b) culti Another aspect of the invention relates to a tissue culture Vating the cotton plants grown from the seeds until the plants of regenerable cells of the cotton variety 14R938B2XF, as bear flowers; c) cross pollinating a flower on one of the two well as plants regenerated therefrom, wherein the regener plants with the pollen of the other plant, and d) harvesting ated cotton plant expresses all the physiological and mor 40 the seeds resulting from the cross pollinating. Still yet another aspect of the invention is a method for phological characteristics of a plant grown from the cotton developing a cotton plant in a cotton breeding program seed designated 14R938B2XF.
Load more

Recommended publications
  • (12) Patent Application Publication (10) Pub. No.: US 2008/0148432 A1 Abad (43) Pub
    US 2008O148432A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2008/0148432 A1 Abad (43) Pub. Date: Jun. 19, 2008 (54) TRANSGENIC PLANTS WITH ENHANCED Publication Classification AGRONOMIC TRAITS (51) Int. Cl. AOIH 5/00 (2006.01) CI2N 5/82 (2006.01) (76) Inventor: Mark Scott Abad, Webster Grove, CI2N 5/04 (2006.01) MO (US) (52) U.S. Cl. ......... 800/279: 800/281; 435/419,435/468; 8OO/320.1 Correspondence Address: (57)57 ABSTRACT MONSANTO COMPANY This invention provides transgenic plant cells with recombi 800 N. LINDBERGHBLVD, ATTENTION: GAIL nant DNA for expression of proteins that are useful for P. WUELLNER, IP PARALEGAL (E2NA) imparting enhanced agronomic trait(s) to transgenic crop ST. LOUIS MO 631.67 9 plants. This invention also provides transgenic plants and 9 progeny seed comprising the transgenic plant cells where the plants are selected for having an enhanced trait selected from the group of traits consisting of enhanced water use effi (21) Appl. No.: 11/374,300 ciency, enhanced cold tolerance, increased yield, enhanced nitrogen use efficiency, enhanced seed protein and enhanced seed oil. Also disclosed are methods for manufacturing trans (22) Filed: Dec. 21, 2005 genic seed and plants with enhanced traits. Patent Application Publication Jun. 19, 2008 Sheet 1 of 3 US 2008/0148432 A1 Figure 1. 41905 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 127 O2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
    [Show full text]
  • Improvement of Lentil (Lens Culinaris Medik.) Through Genetic Transformation
    Improvement of Lentil ( Lens culinaris Medik.) through Genetic Transformation Von der Naturwissenschaftlichen Fakultät Der Gottfried Wilhelm Leibniz Universität Hannover Zur Erlangung des Grades einer DOKTORIN DER NATURWISSENSCHAFTEN Dr. rer. nat. genehmigte Dissertation Von M.Sc. Rehana Hashem Geboren am 23.10.1971 in Dhaka, Bangladesh 2007 Referent: Prof. Dr. Hans - Jörg Jacobsen Korreferent: Prof. Dr. Edgar Maiß Prüfungsvorsitz: Prof. Dr. Bernhard Huchzemeyer Tag der Promotion: 23 February 2007 Dedicated to my beloved parents And My respected teachers ABSTRACT Work title: Improvement of Lentil ( Lens culinaris Medik.) through genetic transformation. Hashem, Rehana The future agriculture will depend more on legume crops because they all have high energy and high protein production for human and animal nutrition as well as amino acid profiles complementary to those of other crops, mainly cereals. The unique symbiotic ability of legumes is to use atmospheric nitrogen for plant growth makes them preferable crops for sustainable agriculture. Lentil is the 2nd most important grain legume that gained worldwide economic importance as a source of protein (25.5 – 28.31 %). In addition, it is also suitable as a rotation crop to replenish soil nitrogen levels. It is a crop of cooler temperature and is widely grown in the temperate zones of the world. The production of lentil is usually considerably below the established yield potential as this crop is very sensitive to particular biotic and abiotic stresses. The most serious biotic attribute constrain in lentils are the foliar diseases such as Ascochyta blight, rust, Stemphylium blight and Botrytis grey mold. Yield stability and productivity and the value of lentil could be greatly increased by the introduction of stably inherited traits such as pest and disease resistance, herbicide resistance or improved protein quality.
    [Show full text]
  • Wo 2009/134339 A2
    (12) INTERNATIONALAPPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date 5 November 2009 (05.11.2009) WO 2009/134339 A2 (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every C12N 15/82 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, (21) International Application Number: CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, PCT/US2009/002547 EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, (22) International Filing Date: HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, 24 April 2009 (24.04.2009) KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, (25) Filing Language: English NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, (26) Publication Language: English SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: 61/125,908 29 April 2008 (29.04.2008) US (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, (71) Applicant (for all designated States except US): MON¬ GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, SANTO TECHNOLOGY, LLC [US/US]; 800 North ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, TJ, Lindbergh Boulevard, St.
    [Show full text]
  • Health Considerations Regarding Horizontal Transfer of Microbial Transgenes Present in Genetically Modified Crops
    Journal of Biomedicine and Biotechnology • 2005:4 (2005) 326–352 • DOI: 10.1155/JBB.2005.326 RESEARCH ARTICLE Health Considerations Regarding Horizontal Transfer of Microbial Transgenes Present in Genetically Modified Crops Gijs A. Kleter, Ad A. C. M. Peijnenburg, and Henk J. M. Aarts RIKILT, Institute of Food Safety, Wageningen University and Research Center, PO Box 230, 6700AE Wageningen, The Netherlands Received 18 October 2004; revised 30 May 2005; accepted 1 June 2005 The potential effects of horizontal gene transfer on human health are an important item in the safety assessment of genetically mod- ified organisms. Horizontal gene transfer from genetically modified crops to gut microflora most likely occurs with transgenes of microbial origin. The characteristics of microbial transgenes other than antibiotic-resistance genes in market-approved genetically modified crops are reviewed. These characteristics include the microbial source, natural function, function in genetically modified crops, natural prevalence, geographical distribution, similarity to other microbial genes, known horizontal transfer activity, selective conditions and environments for horizontally transferred genes, and potential contribution to pathogenicity and virulence in hu- mans and animals. The assessment of this set of data for each of the microbial genes reviewed does not give rise to health concerns. We recommend including the above-mentioned items into the premarket safety assessment of genetically modified crops carrying transgenes other than those reviewed in the present study. INTRODUCTION the Organisation for Economic Cooperation and Devel- The cultivation of genetically modified (GM) crops opment (OECD) and International Life Sciences Institute has rapidly increased since their large-scale commercial (ILSI) have initiated this harmonisation.
    [Show full text]
  • Sachverzeichnis a – Viren (AVV) 434Ff
    629 Sachverzeichnis a – Viren (AVV) 434ff. Aktiengesellschaft (AG) 554ff. a-Faktor 197 Adenosin-Desaminase (ADA)-Mangel 429 Aktionspotenzial 33f., 89 AAV (adeno-assoziierte Viren) 434ff. Adenosin-Phosphorthioate 448 Aktivität Aberration 207 S-Adenosylmethionin (SAM) 146 – Katalysator 485 – chromatische 207 Adenovirus 53, 171f., 433ff. – transkriptionelle 262 – sphärische 207 – AD5-Virus 438 Akzeptor-Farbstoff 278f. ABC-Transporter 33, 51 – Expressionssystem 171 Akzeptor-Molekül Abfallbeseitigung von Industriechemikalien – Gentherapie 513 – fluoreszierendes 214 521 – Vektoren 436ff. Alanin 15f., 293, 318, 335ff. Abl-Onkogen 353 – Wildtyp-Adenoviren 171 Aldose 8f. Abrin A-Kette 370 Adenovirusgenom 171f. Aldosteron 13f., 35 Abschlussgewebe 55 Adenylat-Cyclase 34 Alemtuzumab 370, 416 Abschnitt ADEPT (antibody-directed enzyme pro-drug Alexa Fluor-Farbstoffe 273 – regulatorischer 73ff., 155, 255ff., 300 therapy) 413 Alge 43ff., 56, 94ff., 241, 499 Absorptionsspektrum Adhäsionsprotein 369, 456 Algorithmus – Farbstoff 278 Adipocyt (Fettzelle) 55 – heuristischer 294ff. Abstoßung 448 ADME-T (absorption, distribution, metabolism, Alignment 293ff. – Transplantat 382 excretion, and toxicity) 363 – Algorithmus 301 Abwasserreinigung ADR, s. adverse drug reaction – BLAST (basic local alignment search – anaerobe 507 ADP-Glucose 22 tool) 294 Acetolactat-Synthase-Gen 471 Adrenalin 34 – FASTA 294 Aceton 481, 497, 507 Adsorptionschromatographie 135 – global 294 – Proteinfällung 109 adulte Stammzelle 57 – lokal 294 Acetosyringon 464 Adventivsprossbildung 475
    [Show full text]
  • Title Organization and Regulation of Genes Involved in Nitrile Metabolism in Rhodococcus Rhodochrous J1( Dissertation 全
    Organization and Regulation of Genes Involved in Nitrile Title Metabolism in Rhodococcus rhodochrous J1( Dissertation_全 文 ) Author(s) Komeda, Hidenobu Citation 京都大学 Issue Date 1996-05-23 URL https://doi.org/10.11501/3112279 Right Type Thesis or Dissertation Textversion author Kyoto University Organization and Regulation of Genes Involved in Nitrile Metabolism in Rhodococcus rhodochrous 1 l Hidenobu Komeda 1996 CONTENTS I~ J RO DUCTIO'\ CII APTER I Anal)sis of H igh Molecular-:\-1as ... "-ilrile H)dratase (H-'-lHase) Gen e Cluster Scctton I Re~ulatol) genes for the exprc,ston ol catal~tically active 11-!\Hase SectiOn 2 lno;crtion 'cqucnce IS/ /64 in the H-'\Ha... e gene cluster 15 CHAPTER II Analysis of Low Molecular-Mass Mtrile H) dratase (L-NHase) Gene C lust er Secuon I CX·currenc~ of amidase<> in Rhodococc u.\ rhodochrow J I ..,,... _ Sc<.:lion 2 Amtdase coupled with L-N H a~e: Sequenctng and cxprc,ston of the gene and purification and charactcntAtion or the gene product 26 Section 1 Rcgulatol) genes required for the amtdc dependent induction of L-1\iHasc Section4 Cobalt tram.porter linked 10 L NH a:.e 60 CIIAPTER Ill Genetic Ana l)sis of Nitrilase Secuon I Sequencing and o'erexpression of the nitrilasc gene (mt\) and identification of an essential cysteine residue 73 SectiOn 2 Transcripllonal regulation of meA CON CLUSION 97 RFI< ERENCES 101 ACKNOWLF.I)G EME NTS 107 PUBLIC ATIONS 10~ 1!\TRODUCTIO" ABBRE\'IATIOt'l.~ bp Base pair(s) N1tnlc compounds containing a cyano function.al group such as cyanoglycosidcs.
    [Show full text]
  • Genetic Engineering – Sbb2102
    SCHOOL OF BIO AND CHEMICAL ENGINEERING DEPARTMENT OF BIOTECHNOLOGY UNIT – I – GENETIC ENGINEERING – SBB2102 1 rDNA TECHNOLOGY AND TOOLS INVOLVED IN GENETIC MANIPULATIONS 1. Recombinant DNA Technology: Through the years, scientists have studied the life and how it changes and adapts to the changes in the surroundings. One of their studies to cope up with the changes is through genetic modification. This process has been done indirectly to plants and animals to control their characteristics. Genetic modification is the process of changing the genetic makeup of an organism to express new traits. Modern biotechnology has made it much easier and faster in targeting specific genes to alter through genetic engineering. One of the most known technologies used in genetic engineering is Recombinant DNA Technology. DNA exists in the cells of all living things. These long chains of amino acids serve as the genetic blueprints for living organisms. DNA controls how they form before birth and which traits they pass on to the next generation. Recombinant DNA exists in a laboratory by combining genetic material from multiple sources. Recombinant DNA technology can create new kinds of living organisms or alter the genetic code of existing organisms. As with most technology, there are great benefits and notable downsides to the use of recombinant DNA technology. 1.1.Pros of Recombinant DNA Technology Recombinant DNA technology, sometimes referred to as "genetic engineering," can benefit people in several ways. For example, scientists made artificial human insulin with the help of recombinant DNA technology. Diabetic people cannot produce their own insulin, which they need in order to process sugar.
    [Show full text]
  • 12) United States Patent (10
    US007635572B2 (12) UnitedO States Patent (10) Patent No.: US 7,635,572 B2 Zhou et al. (45) Date of Patent: Dec. 22, 2009 (54) METHODS FOR CONDUCTING ASSAYS FOR 5,506,121 A 4/1996 Skerra et al. ENZYME ACTIVITY ON PROTEIN 5,510,270 A 4/1996 Fodor et al. MICROARRAYS 5,512,492 A 4/1996 Herron et al. 5,516,635 A 5/1996 Ekins et al. (75) Inventors: Fang X. Zhou, New Haven, CT (US); 5,532,128 A 7/1996 Eggers Barry Schweitzer, Cheshire, CT (US) 5,538,897 A 7/1996 Yates, III et al. s s 5,541,070 A 7/1996 Kauvar (73) Assignee: Life Technologies Corporation, .. S.E. al Carlsbad, CA (US) 5,585,069 A 12/1996 Zanzucchi et al. 5,585,639 A 12/1996 Dorsel et al. (*) Notice: Subject to any disclaimer, the term of this 5,593,838 A 1/1997 Zanzucchi et al. patent is extended or adjusted under 35 5,605,662 A 2f1997 Heller et al. U.S.C. 154(b) by 0 days. 5,620,850 A 4/1997 Bamdad et al. 5,624,711 A 4/1997 Sundberg et al. (21) Appl. No.: 10/865,431 5,627,369 A 5/1997 Vestal et al. 5,629,213 A 5/1997 Kornguth et al. (22) Filed: Jun. 9, 2004 (Continued) (65) Prior Publication Data FOREIGN PATENT DOCUMENTS US 2005/O118665 A1 Jun. 2, 2005 EP 596421 10, 1993 EP 0619321 12/1994 (51) Int. Cl. EP O664452 7, 1995 CI2O 1/50 (2006.01) EP O818467 1, 1998 (52) U.S.
    [Show full text]
  • ERMA New Zealand Evaluation and Review Report
    ERMA New Zealand Evaluation and Review Report Application for approval to field test in containment any genetically modified organism Application code: GMF06002 To field test over 10 consecutive years, the vegetable allium species onion, garlic and leek with genetically modified agronomic and quality traits in order to assess their performance in the field and investigate the environmental impacts of these plants Table of contents 1 Introduction ..................................................................................................... 7 2 Information Review ...................................................................................... 11 3 Risk management context ............................................................................. 13 4 Organism identification, description and characterisation............................ 17 5 Containment of the organism ........................................................................ 46 6 Assessment of the ability of the organism to establish a self-sustaining population ..................................................................................................... 80 7 Identification of potentially significant adverse effects and beneficial effects (risks, costs and benefits) .................................................................. 83 8 Assessment of potentially significant adverse and beneficial effects ......... 117 9 Evaluation of additional matters ................................................................. 127 10 Monitoring of effects .................................................................................
    [Show full text]
  • Course Name : BSC Subject Name
    1 Course Name : BSC Subject Name: Plant Biotechnology Prepared by Assistant Professor’s Team of Microtek College of Management & Technology Under Guidance of Dr. Pankaj Rajhans An Alumni of IIT-Delhi President & Executive Director Microtek College of Management & Technology Jaunpur & Varanasi (U.P) 2 Unit I Plant genome organization (Page 3-8) Structure of representative plant genes Gene families in plants Organisation of chloroplast genome Nuclear encoded and chloroplast encoded genes for chloroplast proteins Targeting of proteins to chloroplast Organisation of mitochondrial genome - encoded genes for mitochondrial proteins RNA editing for plant mitochondria Cytoplasmic male sterility Seed storage proteins Maize transposable elements, their organisation and function Transposabie elements in transgenic plants Regulation of gene expression in plant development -Plant hormones and phytochrome Unit II Symbiotic nitrogen fixation in legumes by Rhizobia Nitrogen fixation in Cyanophyta the biochemistry molecular biology and gene rearrangement Agrobacterium and crown gall tumors Mechanism of TDNA transfer to plants Ti plasmid vectors and its utility Classification and molecular biology of plant viruses Molecular biology of -plant stress response Transgenic plants and applications vaccine and other biological developments Unit III Genetic engineering in plants Selectable' markers Reporter genes and promoter used in plants by physical means Genetic engineering of plants for construction of genome libraries and CDNA libraries Molecular breeding 3 PLANT BIOTECHNOLOGY Plant Genome - Genetically, a plant genome is the most complex one found in living systems. It comprises three interacting genome. Aside from the nuclear genome, complete genetic systems are located in the plastids and the mitochondria. These organelles are semiautonomous bodies; they have their own organizational and functional properties but do not synthesize all their own proteins.
    [Show full text]
  • All Enzymes in BRENDA™ the Comprehensive Enzyme Information System
    All enzymes in BRENDA™ The Comprehensive Enzyme Information System http://www.brenda-enzymes.org/index.php4?page=information/all_enzymes.php4 1.1.1.1 alcohol dehydrogenase 1.1.1.B1 D-arabitol-phosphate dehydrogenase 1.1.1.2 alcohol dehydrogenase (NADP+) 1.1.1.B3 (S)-specific secondary alcohol dehydrogenase 1.1.1.3 homoserine dehydrogenase 1.1.1.B4 (R)-specific secondary alcohol dehydrogenase 1.1.1.4 (R,R)-butanediol dehydrogenase 1.1.1.5 acetoin dehydrogenase 1.1.1.B5 NADP-retinol dehydrogenase 1.1.1.6 glycerol dehydrogenase 1.1.1.7 propanediol-phosphate dehydrogenase 1.1.1.8 glycerol-3-phosphate dehydrogenase (NAD+) 1.1.1.9 D-xylulose reductase 1.1.1.10 L-xylulose reductase 1.1.1.11 D-arabinitol 4-dehydrogenase 1.1.1.12 L-arabinitol 4-dehydrogenase 1.1.1.13 L-arabinitol 2-dehydrogenase 1.1.1.14 L-iditol 2-dehydrogenase 1.1.1.15 D-iditol 2-dehydrogenase 1.1.1.16 galactitol 2-dehydrogenase 1.1.1.17 mannitol-1-phosphate 5-dehydrogenase 1.1.1.18 inositol 2-dehydrogenase 1.1.1.19 glucuronate reductase 1.1.1.20 glucuronolactone reductase 1.1.1.21 aldehyde reductase 1.1.1.22 UDP-glucose 6-dehydrogenase 1.1.1.23 histidinol dehydrogenase 1.1.1.24 quinate dehydrogenase 1.1.1.25 shikimate dehydrogenase 1.1.1.26 glyoxylate reductase 1.1.1.27 L-lactate dehydrogenase 1.1.1.28 D-lactate dehydrogenase 1.1.1.29 glycerate dehydrogenase 1.1.1.30 3-hydroxybutyrate dehydrogenase 1.1.1.31 3-hydroxyisobutyrate dehydrogenase 1.1.1.32 mevaldate reductase 1.1.1.33 mevaldate reductase (NADPH) 1.1.1.34 hydroxymethylglutaryl-CoA reductase (NADPH) 1.1.1.35 3-hydroxyacyl-CoA
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2015/0240226A1 Mathur Et Al
    US 20150240226A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2015/0240226A1 Mathur et al. (43) Pub. Date: Aug. 27, 2015 (54) NUCLEICACIDS AND PROTEINS AND CI2N 9/16 (2006.01) METHODS FOR MAKING AND USING THEMI CI2N 9/02 (2006.01) CI2N 9/78 (2006.01) (71) Applicant: BP Corporation North America Inc., CI2N 9/12 (2006.01) Naperville, IL (US) CI2N 9/24 (2006.01) CI2O 1/02 (2006.01) (72) Inventors: Eric J. Mathur, San Diego, CA (US); CI2N 9/42 (2006.01) Cathy Chang, San Marcos, CA (US) (52) U.S. Cl. CPC. CI2N 9/88 (2013.01); C12O 1/02 (2013.01); (21) Appl. No.: 14/630,006 CI2O I/04 (2013.01): CI2N 9/80 (2013.01); CI2N 9/241.1 (2013.01); C12N 9/0065 (22) Filed: Feb. 24, 2015 (2013.01); C12N 9/2437 (2013.01); C12N 9/14 Related U.S. Application Data (2013.01); C12N 9/16 (2013.01); C12N 9/0061 (2013.01); C12N 9/78 (2013.01); C12N 9/0071 (62) Division of application No. 13/400,365, filed on Feb. (2013.01); C12N 9/1241 (2013.01): CI2N 20, 2012, now Pat. No. 8,962,800, which is a division 9/2482 (2013.01); C07K 2/00 (2013.01); C12Y of application No. 1 1/817,403, filed on May 7, 2008, 305/01004 (2013.01); C12Y 1 1 1/01016 now Pat. No. 8,119,385, filed as application No. PCT/ (2013.01); C12Y302/01004 (2013.01); C12Y US2006/007642 on Mar. 3, 2006.
    [Show full text]